[Mutagenicity of methyl 2--benzimidazole carbamate (carbendazim) in the in vivo and in vitro tests].
D000818:Animals; D001562:Benzimidazoles / Q000633:toxicity*; D002219:Carbamates; D002467:Cell Nucleus / Q000378:metabolism; D004247:DNA / Q000096:biosynthesis; D004261:DNA Replication / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D009152:Mutagenicity Tests / Q000379:methods; D009154:Mutation; D051381:Rats; D011919:Rats, Inbred Strains; D012486:Salmonella typhimurium / Q000235:genetics; D013737:Testis / Q000648:ultrastructure*
D001562:Benzimidazoles; D002219:Carbamates; D004247:DNA; C006698:carbendazim
Mutagenność 2-benzimidazolokarbaminianu metylu (karbendazymu) w testach in vivo i in vitro.